chikungunya
viru
chikv
mosquitoborn
alphaviru
caus
epidem
fever
rash
polyarthralgia
africa
asia
although
known
sinc
new
epidemiolog
clinic
featur
report
recent
outbreak
indian
ocean
regard
emerg
new
diseas
numer
sever
form
infect
describ
put
emphasi
lack
effici
antivir
therapi
among
virusencod
enzym
constitut
attract
target
develop
antivir
drug
multifunct
protein
approxim
kda
helicas
motif
ntermin
portion
protein
papainlik
proteas
activ
resid
ctermin
portion
proteinas
essenti
enzym
whose
proteolyt
activ
critic
viru
replic
work
recombin
chikv
ctermin
truncat
variant
express
escherichia
coli
purifi
metalchel
chromatographi
enzymat
properti
proteinas
determin
use
specif
synthet
fluorogen
substrat
studi
constitut
first
character
recombin
chikv
cystein
proteas
may
use
futur
drug
screen
chikungunya
viru
genu
alphaviru
famili
togavirida
transmit
aed
mosquito
porterfield
strauss
strauss
typic
respons
human
acut
ill
includ
fever
maculopapular
rash
incapacit
arthralgia
robinson
johnston
peter
jupp
cornel
isol
first
time
tanzanian
outbreak
ross
chikv
geograph
distribut
africa
india
southeast
asia
lam
et
al
pastorino
et
al
saluzzo
et
al
africa
describ
endem
sylvat
cycl
involv
wild
primat
human
mosquito
genu
aed
power
et
al
howev
last
year
larg
urban
outbreak
also
report
central
africa
pastorino
et
al
due
recent
extens
around
indian
ocean
includ
comoro
mauritiu
reunion
island
madagascar
india
bessaud
et
al
charrel
et
al
schuffeneck
et
al
ravi
italia
chikv
regard
potenti
worldwid
public
health
problem
prevent
therapeut
mean
avail
sindbi
viru
sinv
semliki
forest
viru
sfv
studi
extens
molecular
level
serv
model
determin
alphaviru
architectur
replic
strategi
genom
alphavirus
singl
rna
molecul
posit
polar
kb
length
encod
four
nonstructur
protein
essenti
compon
viral
replicas
transcriptas
function
protein
first
express
polyprotein
cleav
viral
proteas
protein
multifunct
hardi
strauss
merit
et
al
strauss
et
al
vasiljeva
et
al
nucleosid
triphosphatas
helicas
rnadepend
activ
locat
nterminu
protein
proteolyt
domain
map
ctermin
part
form
papainlik
thiol
proteas
catalyt
dyad
involv
two
conserv
residu
c
h
proteas
respons
cleavag
nonstructur
polyprotein
kim
et
al
vasiljeva
et
al
crucial
viral
replic
cycl
therefor
proteas
constitut
attract
target
develop
antivir
compound
previou
function
map
sfv
defin
solubl
region
proteas
activ
call
sfv
residu
c
chikv
sequenc
determin
align
chikv
genbank
access
number
sinv
sfv
amino
acid
sequenc
residu
e
c
use
clustal
x
softwar
thompson
et
al
overal
sequenc
conserv
nucleotid
level
aminoacid
level
chikv
sequenc
compar
sfv
catalyt
residu
c
h
found
invari
three
sequenc
well
w
shown
necessari
proteolyt
activ
golubtsov
et
al
strauss
et
al
base
sequenc
analysi
construct
two
specif
plasmid
use
vector
follow
specif
gateway
clone
technolog
invitrogen
cergi
pontois
franc
primer
genom
posit
aaaaagcaggctctgaaggagatagaaccatgtggaaagacactctccggt
genom
posit
agaaagctgggtaacatcctgctcgggtggc
use
first
construct
express
chikv
residu
w
residu
c
primer
genom
posit
agaaagctgggtagaccaggagcacgtggtg
use
second
construct
residu
w
residu
v
chikv
express
escherichia
coli
ril
stratagen
mm
iptg
h
c
tb
media
fig
two
recombin
protein
partial
solubl
differ
condit
test
addit
denatur
agent
deterg
glycylglycin
ghosh
et
al
fail
improv
protein
solubl
purif
perform
use
metalchel
chromatographi
ninta
qiagen
courtaboeuf
franc
load
onto
column
amersham
bioscienc
orsay
franc
connect
fplc
system
amersham
bioscienc
purif
coomassiestain
sdspage
reveal
addit
band
accompani
recombin
protein
use
co
matrix
increas
wash
step
stringenc
well
size
exclus
superdex
column
amersham
ion
exchang
mono
q
column
amersham
chromatographi
improv
puriti
rate
main
contamin
protein
identifi
malditofm
analysi
chaperon
protein
htpg
e
coli
molecular
weight
da
number
swissprottrembl
htpg
alreadi
describ
recombin
protein
overproduc
e
coli
rikkonen
et
al
liberek
et
al
sherman
goldberg
elong
factor
efca
e
coli
molecular
weight
da
protein
display
proteas
activ
wash
ninta
purifi
fraction
mgatp
rial
ceccarelli
purpos
elimin
chaperon
protein
htpg
result
concomit
loss
substanti
proport
recombin
protein
data
shown
ident
verifi
immunoblot
use
antihi
monoclon
antibodi
fig
purif
step
protein
concentr
determin
puriti
close
use
lumiimag
imag
system
roch
appli
scienc
meylan
franc
purifi
protein
sampl
concentr
use
vivaspin
concentr
vivasci
hannov
germani
character
enzymat
activ
purifi
proteas
investig
abil
cleav
substrat
kind
substrat
previous
use
studi
activ
iti
wide
rang
proteas
eukaryot
viral
trypsinlik
proteas
jeohn
et
al
kato
et
al
bessaud
et
al
yusof
et
al
cystein
proteas
choe
et
al
melo
et
al
gosalia
et
al
short
substrat
use
assay
catalyt
activ
proteas
map
specif
nonprim
site
residu
p
p
p
p
posit
accord
schechter
berger
nomenclatur
thought
import
cleavag
enzym
recogn
substrat
small
residu
posit
specif
g
site
lulla
et
al
take
account
data
design
two
synthet
peptid
bocagamca
bocaggmca
jpt
peptid
technolog
berlin
germani
repres
natur
nonprim
part
chikv
cleavag
site
respect
two
substrat
found
cleav
contrast
activ
bocagamca
bocaggmca
substrat
detect
use
proteas
even
enzymat
concentr
result
confirm
function
import
ctermin
region
proteas
activ
absenc
proteas
contamin
activ
recombin
protein
prepar
previou
studi
shown
sfv
proteas
activ
inhibit
delet
carboxyltermin
domain
recent
venezuelan
equin
enceph
viru
veev
proteas
structur
resolv
russo
watowich
provid
evid
ctermin
moieti
may
contribut
substrat
recognit
thu
ctermin
region
alphaviru
could
fill
role
similar
cofactor
flavivirusencod
proteas
aleshin
et
al
tripeptid
substrat
bocaggmca
use
determin
optim
condit
enzymat
activ
ph
depend
proteolyt
process
studi
constant
ionic
strength
optim
ph
enzym
catalysi
determin
fig
enzymat
activ
higher
ph
decreas
rapidli
rang
alreadi
case
other
purifi
viral
recombin
proteas
bessaud
et
al
li
singh
nall
et
al
shiryaev
et
al
exist
alkalin
optim
ph
could
indic
proteolysi
regul
process
vivo
physiolog
ph
cytoplasm
chikv
proteas
activ
slightli
inhibit
nacl
fig
optim
activ
valu
obtain
nacl
concentr
mm
increas
salt
concentr
mm
result
decreas
proteas
activ
result
explain
import
electrostat
interact
cystein
proteasesubstr
bind
overproduc
recombin
protein
tendenc
aggreg
shown
addit
glycerol
neutral
deterg
could
enhanc
target
activ
increas
access
enzym
site
substrat
bessaud
et
al
leung
et
al
nall
et
al
howev
chikv
process
activ
significantli
inhibit
glycerol
addit
glycerol
concentr
proteas
activ
alreadi
decreas
drop
glycerol
fig
ph
data
point
rel
activ
defin
ratio
v
v
ph
b
effect
ionic
strength
observ
buffer
contain
tri
mm
ph
vari
concentr
nacl
data
point
rel
activ
defin
ratio
v
v
mm
c
effect
glycerol
data
point
rel
activ
defin
ratio
therefor
optim
experiment
condit
determin
tri
mm
ph
nacl
mm
optim
condit
purifi
chikv
proteas
show
reduc
activ
substrat
bocagamca
compar
bocaggmca
tabl
bocagamca
substrat
k
k
cat
respect
time
time
higher
valu
obtain
bocaggmca
substrat
kinet
comparison
show
chikv
proteas
higher
substrat
affin
bocaggmca
substrat
result
effici
cleavag
result
consist
alphaviru
replic
cycl
speed
process
play
crucial
role
control
rna
synthesi
lemm
rice
lemm
et
al
shirako
strauss
alphaviru
nonprim
substrat
sequenc
indic
bold
prime
substrat
sequenc
shown
ital
proteas
activ
assay
tri
mm
ph
nacl
mm
use
substrat
concentr
rang
standard
reaction
contain
chikv
proteas
concentr
kinet
paramet
degrad
dabcylagagiieedan
determin
nd
low
activ
proteas
toward
substrat
infect
cell
nonstructur
polyprotein
cleav
three
site
specif
order
site
rapidli
cleav
infect
cleavag
absolut
essenti
viru
replic
virusspecif
rna
synthesi
kim
et
al
lemm
et
al
similar
data
previous
report
proteas
sfv
sinv
lulla
et
al
vasiljeva
et
al
optimis
assay
also
perform
use
longer
quench
fluorogen
heptaand
octapeptid
eurogentec
sa
belgium
overlap
natur
cleavag
site
tabl
order
identifi
role
flank
sequenc
proteolyt
activ
protein
inact
substrat
wherea
enzymat
activ
detect
use
recombin
proteas
highest
activ
obtain
use
fluorogen
peptid
overlap
natur
cleavag
site
confirm
previou
result
obtain
mca
peptid
chikv
proteas
show
higher
affin
authent
substrat
shorter
bocaggmca
k
cat
k
ratio
almost
similar
heptapeptid
substrat
correspond
natur
cleavag
site
poorli
cleav
therefor
abl
determin
correspond
enzymat
constant
degrad
result
could
consequ
poor
substrat
solubl
due
rel
high
rate
hydrophob
residu
f
heptapeptid
sequenc
petrassi
et
al
insight
proteas
catalyt
mechan
effect
differ
proteas
inhibitor
enzymat
activ
chikv
also
test
use
costeffect
bocaggmca
peptid
substrat
fig
expect
enzym
complet
resist
inhibitor
serin
proteas
aebsf
aprotinin
aspart
proteas
pepstatin
metalloproteas
edta
also
resist
one
cystein
proteas
inhibitor
leupeptin
howev
cleavag
bocaggmca
substrat
complet
inhibit
mm
nethylmaleimid
nem
mm
dival
cation
zn
cu
result
consist
classif
thiol
proteinas
papain
superfamili
data
alreadi
describ
cathepsin
b
lockwood
papainlik
proteas
sever
acut
respiratori
syndrom
coronaviru
sarscov
han
et
al
howev
mechan
zn
cu
fe
inhibit
unclear
due
lack
molecular
structur
avail
divers
low
similar
insid
papainlik
cystein
proteas
famili
russo
watowich
interest
note
zinc
zinc
conjug
proven
effect
inhibit
sarscov
replic
vivo
simultan
inhibit
sarscov
proteas
hsu
et
al
zinc
salt
zinc
acet
alreadi
use
therapeut
human
could
repres
promis
drug
treatment
viral
infect
success
retrovir
proteas
inhibit
earli
promis
shown
inhibitor
hepat
c
viru
lin
et
al
demonstr
feasibl
interest
antivir
strategi
base
proteas
inhibit
function
assay
one
develop
work
allow
highthroughput
screen
chemic
librari
search
inhibitor
help
character
alphavirus
proteas
work
partial
fund
french
arm
forc
medic
servic
french
pour
larmement
dga
contrat
dobjectif
opinion
assert
contain
herein
author
constru
offici
reflect
view
french
arm
forc
medic
servic
french
armi
larg
